Is the US prepared to deal with another pandemic or widespread health crisis?
I will research recent assessments of U.S. pandemic and health crisis preparedness from government agencies, independent experts, and reports.No, the US is not fully prepared for another pandemic or widespread health crisis, though it is better positioned in several tactical areas than before COVID-19 and ranks highly on international benchmarks. Preparedness remains incomplete due to chronic structural gaps, funding inconsistencies, leadership/coordination challenges, and the “panic-and-neglect” cycle that follows major outbreaks. Assessments from bipartisan commissions, government reports, and experts consistently highlight both progress and significant vulnerabilities.[1]
Strengths and Improvements
The US leads or ranks near the top of the Global Health Security (GHS) Index (e.g., #1 with 83.5/100 in 2019; overall 75.9 in 2021), reflecting strong capabilities in detection/reporting (lab systems, real-time surveillance, epidemiology workforce), prevention (biosafety, immunization, AMR efforts), and certain response elements.[2][3]
Post-COVID advances include:
These build on America’s unmatched biomedical innovation ecosystem, private-sector partnerships, and federal resources.
Persistent Gaps and Challenges
The Bipartisan Commission on Biodefense’s 2024 National Blueprint states that “immediate action [is] needed” and that the nation remains “dangerously unprepared” or “dangerously vulnerable” despite some progress. It notes the biological threat is real and growing (natural, accidental, or deliberate), with fragmented leadership across 15+ departments/agencies, inadequate sustained funding, outdated detection (e.g., calls to replace BioWatch), and insufficient emphasis on getting ahead of threats rather than just responding. It recommends stronger White House leadership (e.g., National Security Advisor role), a unified biodefense budget, quadrennial reviews, and dozens of specific reforms.[1][7][8]
Other key issues:
COVID exposed that high GHS Index scores do not guarantee effective real-world performance when political will, equity, communication, and basic public health capacity falter. International comparisons and after-action reviews emphasize the need for sustained investment beyond emergency funding.
Bottom Line
The US has world-class scientific, manufacturing, and logistical strengths that would enable a faster and more effective response than in early 2020 for many scenarios—especially with better stockpiles, platforms, and data systems. However, it is not adequately prepared for a severe, prolonged, or novel pandemic/health crisis. Structural weaknesses in public health foundations, consistent leadership/funding, equity, and whole-of-society coordination mean outcomes would still involve substantial preventable morbidity, mortality, economic disruption, and social strain. Experts and bipartisan analyses urge sustained reforms, multi-year funding, modernized detection/surveillance, stronger White House coordination, and addressing domestic health system gaps to break the cycle of inadequate readiness. Preparedness is an ongoing process, not a fixed state, and current trajectories (including policy shifts) introduce new uncertainties.
Citations (15)
- https://biodefensecommission.org/reports/the-national-blueprint-for-biodefense/
Backs: “Assessments from bipartisan commissions, government reports, and experts consistently highlight both progress and significant vulnerabilities.”
- https://ghsindex.org/country/united-states/
Backs: “The US leads or ranks near the top of the Global Health Security (GHS) Index (e.g., #1 with 83.5/100 in 2019; overall 75.9 in 2021), reflecting strong capabilities in detection/reporting (lab systems, real-time surveillance, epidemiology workforce), prevention (biosafety, immunization, AMR efforts), and certain…”
- https://www.statista.com/statistics/1421172/global-health-security-ghs-index-of-the-us/
Backs: “The US leads or ranks near the top of the Global Health Security (GHS) Index (e.g., #1 with 83.5/100 in 2019; overall 75.9 in 2021), reflecting strong capabilities in detection/reporting (lab systems, real-time surveillance, epidemiology workforce), prevention (biosafety, immunization, AMR efforts), and certain…”
- https://bidenwhitehouse.archives.gov/briefing-room/statements-releases/2025/01/14/report-the-biden-harris-administration-roadmap-for-pandemic-preparedness-and-response/
Backs: “Dramatically increased PPE (e.g., ~70× N95 respirators, 34× gloves, 50× isolation gowns) and ventilators compared to pre-pandemic levels, enabling support for H5N1, mpox, an”
- https://www.niaid.nih.gov/news-events/nih-awards-establish-pandemic-preparedness-research-network
Backs: “BARDA and related efforts support countermeasure development; the “100 Days Mission” aims for faster vaccines/diagnostics/therapeutics. Domestic manufacturing investments and onshoring of APIs/pharma ingredients aim to reduce supply-chain risks.”
- https://www.cdc.gov/washington/testimony/2024/t20241114.htm
Backs: “CDC and partners have built “warm base” lab capacity and improved testing/vaccine infrastructure.”
- https://www.axios.com/2024/05/07/biodefense-buildup-urged-exclusive-report
Backs: “It recommends stronger White House leadership (e.g., National Security Advisor role), a unified biodefense budg”
- https://www.prnewswire.com/news-releases/nation-dangerously-unprepared-for-deadly-outbreaks-and-biological-attacks-302136825.html
Backs: “It recommends stronger White House leadership (e.g., National Security Advisor role), a unified biodefense budget, quadrennial reviews, and dozens of specific reforms.[[1]](https://biodefensec”
- http://aspe.hhs.gov/reports/measuring-preparedness
Backs: “Public health infrastructure and workforce: Long-term underfunding, burnout, and shortages limit surge capacity, contact tracing, and local response.”
- https://www.commonwealthfund.org/blog/2023/lessons-covid-19-can-help-us-prepare-next-pandemic
Backs: “Health system limitations: Uneven hospital surge capacity, access/affordability disparities, and insurance gaps exacerbate impacts (as seen in COVID’s disproportionate effects). The US health system underperforms peers on many equity and outcomes metrics despite high spending.”
- https://www.stimson.org/2024/prepare-for-the-next-biothreat-now/
Backs: “Recent years have seen proposed or enacted cuts to biodefense, global health security, and certain R&D (including concerns over mRNA programs), plus disruptions to coordination offices and international partnerships.”
- https://www.science.org/content/article/trump-administration-dismantling-efforts-fight-next-pandemic
Backs: “Recent years have seen proposed or enacted cuts to biodefense, global health security, and certain R&D (including concerns over mRNA programs), plus disruptions to coordination offices and international part”
- https://councilonstrategicrisks.org/2025/12/09/us-biodefense-budget-breakdown-fiscal-year-2026-update/
Backs: “Many GAO COVID-related recommendations remain unimplemented.[[11]](https://www.stimson.org/2024/pr”
- https://clpmag.com/resource-center/research/abbott-survey-reveals-gaps-in-pandemic-preparedness/
Backs: “Detection of novel or engineered pathogens and rapid attribution remain imperfect. Expert surveys note ongoing gaps in surveillance programs, testing infrastructure, and public health funding.”
- https://reliefweb.int/report/world/changing-face-pandemic-risk-2024
Backs: “Expert surveys note ongoing gaps in surveillance programs, testing infr”